Welcome to LookChem.com Sign In|Join Free

CAS

  • or

4449-51-8

Post Buying Request

4449-51-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Spiro[9H-benzo[a]fluorene-9,2'(3'H)-furo[3,2-b]pyridin]-3-ol,1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-octadecahydro-3',6',10,11b-tetramethyl-,(2'R,3S,3'R,3'aS,6'S,6aS,6bS,7'aR,11aS,11bR)-

    Cas No: 4449-51-8

  • No Data

  • 1 Gram

  • 10000 Metric Ton/Month

  • Shanghai Upbio Tech Co.,Ltd
  • Contact Supplier

4449-51-8 Usage

Description

Cyclopamine is a natural steroidal alkaloid that inhibits signaling through the hedgehog pathway at the level of the pathway activator Smoothened. By altering gene expression in this signaling sequence, cyclopamine induces defects in morphogenesis, first observed in chicks and sheep as cyclopia. As a readout of action, cyclopamine inhibits hedgehog-dependent expression of Pax7 with an IC50 value of 24 nM. Although teratogenic during development, cyclopamine has potential applications in the treatment of cancer. It is a white crystalline solid.

Uses

1. Used in Pharmaceutical Industry:
Cyclopamine is used as a hedgehog [Hh] signaling pathway and Smo inhibitor for its potential applications in the treatment of cancer. It depletes stem-like cancer cells in glioblastoma and blocks tumor engraftment.
2. Used in Cancer Research:
Cyclopamine is used as a tool in cancer research to study the effects of oncogenic mutations in Smoothened and Patched, as it has been shown to reverse these effects.
3. Used in Stem Cell Differentiation:
Cyclopamine is used to induce differentiation of human embryonic stem cells (hESCs) into hormone-expressing endocrine cells.
4. Used in Antimicrobial Applications:
Cyclopamine is used for its antibacterial properties, providing a potential application in the development of new antimicrobial agents.
5. Used in Teratogenic Studies:
Cyclopamine demonstrates teratogenic properties and has been used in studies to understand the effects of teratogens on developmental processes.

Cyclopamine

cyclopamine is a ?isosteroidal alkaloid isolated from Veratrum plant , it mainly exists in four kinds of liliaceous plants which include North America Veratrum californicum , Indian Cornlily and Veratrum grandiflorum , Fritillaria pallidiflora Schrenk ,it can be combined with the Smoothened (Smo) protein in Hedgehog signaling pathway , thereby inhibiting the protein activity. It was discovered in the 1960s because of its teratogenic effects , but later nineties studies show that cyclopamine is a hedgehog signaling pathway inhibitor, it has been demonstrated in Drosophila body, since the hedgehog signaling pathway mutations are associated with the pathogenesis of a variety of tumors , recent studies have found that cyclopamine have anti-tumor effects in the adult, which has been confirmed in experiments in vivo or in vitro about pancreatic cancer, bile duct cancer, ovarian cancer, liver cancer and others , but on its researches about gastric cancer cells,it has not been reported in the country . Currently cyclopamine as a potential anti-cancer drug in the world sets off a wave of research. The above information is edited by the lookchem of Tian Ye.

Biological Activity

Inhibitor of hedgehog (Hh) signaling, likely via direct inhibition of Smoothened, the accessory protein to the putative Hh receptor Patched. Anti-cancer and teratogenic in vivo . Depletes stem-like cancer cells in glioblastoma and blocks tumor engraftment.

Anticancer Research

Cyclopamine is a natural compound that inhibits the Hedgehog signaling pathway.Cyclopamine targets Hedgehog by specifically hindering SMO activation.Cyclopamine therapy of murine medulloblastoma resulted in the inhibition ofproliferation, induction of neuronal differentiation, effective depletion of CSCs, andreduction of tumor burden in a mouse tumor allograft. Cyclopamine is effective inkilling of pancreatic, breast, and multiple myeloma CSCs. Cyclopamine incombination with gemcitabine inhibits metastatic spread and reduces primary tumorburden in pancreatic orthotopic xenografts. Mammosphere formation in breastcarcinoma and SC proliferation in multiple myeloma can be reduced by cyclopamine(Kawasaki et al. 2008). The HH ligand activation requires cholesterol at theircarboxyl ends, and 22-OH-cholesterol and 20-OH-cholesterol are reported toincrease the HH target gene expression, and this hypothesis of cholesterol-dependentHH signal transduction is investigated in M2-10B4 pluripotent mesenchymal stemcells. The mechanism underlying the positive regulation of HH signaling by theseoxidative species of cholesterol is not clear. However, this oxidative status ofcholesterol is altered by the endogenous ROS. Hence, the bioactive food componentsthat control the ROS levels can be important in regulating self-renewal and HHpathways (Kim et al. 2012). Cholecalciferol (vitamin D3, an isoform of vitamin D)is reported to be HH antagonist in vitro but not in vivo. Binding of cholecalciferol toSMO receptors results in the reduction of HH signaling in MDAMB231 andC3H/10 T1/2 fibroblast cells. 1 μM vitamin D3 shows more potent SMO inhibitoryaction than 10 μM cyclopamine in PTCH1-transfected C3H/10 T1/2 cells (Kimet al. 2012). Curcumin interferes with the Gli1 mRNA or Gli reporter activity andinhibits HH signaling in transgenic mouse prostate adenocarcinoma cells (Kimet al. 2012).

References

1) Watkins et al. (2003), Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer; Nature, 422 313

Check Digit Verification of cas no

The CAS Registry Mumber 4449-51-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,4,4 and 9 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 4449-51:
(6*4)+(5*4)+(4*4)+(3*9)+(2*5)+(1*1)=98
98 % 10 = 8
So 4449-51-8 is a valid CAS Registry Number.
InChI:InChI=1/C27H41NO2/c1-15-11-24-25(28-14-15)17(3)27(30-24)10-8-20-21-6-5-18-12-19(29)7-9-26(18,4)23(21)13-22(20)16(27)2/h5,15,17,19-21,23-25,28-29H,6-14H2,1-4H3/t15-,17+,19-,20-,21-,23-,24+,25-,26-,27-/m0/s1

4449-51-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Cyclopamine

1.2 Other means of identification

Product number -
Other names 11-DEOXYJERVINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4449-51-8 SDS

4449-51-8Synthetic route

C33H45NO4S
1198184-95-0

C33H45NO4S

cyclopamine
4449-51-8

cyclopamine

Conditions
ConditionsYield
Stage #1: C33H45NO4S With naphthalene; sodium In 1,2-dimethoxyethane at -78℃; for 3h; Inert atmosphere;
Stage #2: With water; sodium hydrogencarbonate In 1,2-dimethoxyethane at -78 - 20℃; Inert atmosphere;
91%
jervine
469-59-0

jervine

cyclopamine
4449-51-8

cyclopamine

Conditions
ConditionsYield
With potassium hydroxide; hydrazine hydrate Heating; 1.) triethylene glycol, 120 deg C, 1 h, 2.) triethylene glycol, 200 deg C, 3 h;51%
With sodium; hydrazine In diethylene glycol Heating;
C35H46N2O7
1224886-42-3

C35H46N2O7

A

4-hydroxymethyl-2-nitrophenol
41833-13-0

4-hydroxymethyl-2-nitrophenol

B

cyclopamine
4449-51-8

cyclopamine

Conditions
ConditionsYield
With water at 37℃; pH=7; aq. phosphate buffer; Inert atmosphere;
C56H79N5O21

C56H79N5O21

A

C22H32N4O12
1366596-68-0

C22H32N4O12

B

cyclopamine
4449-51-8

cyclopamine

Conditions
ConditionsYield
With b-glucuronidase from E. Coli at 37℃; for 2h; pH=7; aq. phosphate buffer; Enzymatic reaction;
cycloposine

cycloposine

cyclopamine
4449-51-8

cyclopamine

Conditions
ConditionsYield
With water; 2-amino-2-hydroxymethyl-1,3-propanediol In ethanol; dimethyl sulfoxide at 37℃; for 22h; pH=7.2; pH-value; Reagent/catalyst; Solvent; Temperature; Enzymatic reaction;
cyclopamine
4449-51-8

cyclopamine

cyclopamine-4-ene-3-one

cyclopamine-4-ene-3-one

Conditions
ConditionsYield
With aluminum isopropoxide; butanone for 6.5h; Oppenauer oxidation; Reflux;99%
With aluminum isopropoxide; butanone for 6.5h; Oppenauer oxidation; Reflux; Inert atmosphere;85%
With cyclohexanone; aluminum isopropoxide In toluene for 2h; Heating / reflux;70%
With cyclohexanone; aluminum isopropoxide In toluene for 2h; Heating / reflux;70%
cyclopamine
4449-51-8

cyclopamine

propargyl bromide
106-96-7

propargyl bromide

N-propargylcyclopamine
1017893-81-0

N-propargylcyclopamine

Conditions
ConditionsYield
With sodium hydrogencarbonate In toluene; acetonitrile for 2.5h; Heating;94%
With sodium hydrogencarbonate In toluene; acetonitrile for 2.5h; Reflux;94%
cyclopamine
4449-51-8

cyclopamine

benzyl chloroformate
501-53-1

benzyl chloroformate

bis-CBz-cyclopamine
1037210-08-4

bis-CBz-cyclopamine

Conditions
ConditionsYield
With dmap; triethylamine In 1-Propyl acetate at 20℃; for 4h; Inert atmosphere; Large scale;91.8%
C46H58N8O14

C46H58N8O14

cyclopamine
4449-51-8

cyclopamine

C73H97N9O15

C73H97N9O15

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 6h;85%
C38H36N2O20

C38H36N2O20

cyclopamine
4449-51-8

cyclopamine

C59H72N2O19

C59H72N2O19

Conditions
ConditionsYield
With pyridine In N,N-dimethyl-formamide at 20℃; for 20h;85%
cyclopamine
4449-51-8

cyclopamine

(9H-fluoren-9-yl)methyl (6-oxohexyl)carbamate
228715-38-6

(9H-fluoren-9-yl)methyl (6-oxohexyl)carbamate

C48H64N2O4

C48H64N2O4

Conditions
ConditionsYield
With sodium tris(acetoxy)borohydride In 1,2-dichloro-ethane at 20℃;85%
N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide
82911-69-1

N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide

cyclopamine
4449-51-8

cyclopamine

Fmoc-cyclopamine
1073511-50-8

Fmoc-cyclopamine

Conditions
ConditionsYield
In dichloromethane at 23℃; for 64h; Inert atmosphere;81%
In dichloromethane at 20℃;
C49H67N11O14
1029122-18-6

C49H67N11O14

cyclopamine
4449-51-8

cyclopamine

C76H106N12O15
1029122-26-6

C76H106N12O15

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 6h;80%
cyclopamine
4449-51-8

cyclopamine

(2S,3S,4S,5R,6S)-3,4,5-Triacetoxy-6-[2-nitro-4-(4-nitro-phenoxycarbonyloxymethyl)-phenoxy]-tetrahydro-pyran-2-carboxylic acid methyl ester
148580-01-2

(2S,3S,4S,5R,6S)-3,4,5-Triacetoxy-6-[2-nitro-4-(4-nitro-phenoxycarbonyloxymethyl)-phenoxy]-tetrahydro-pyran-2-carboxylic acid methyl ester

C48H62N2O16
1224886-43-4

C48H62N2O16

Conditions
ConditionsYield
With pyridine In N,N-dimethyl-formamide at 20℃; for 12h; Inert atmosphere;76%
C9H14O5

C9H14O5

cyclopamine
4449-51-8

cyclopamine

C36H53NO6

C36H53NO6

Conditions
ConditionsYield
Stage #1: C9H14O5 With N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In dichloromethane at 20℃; for 0.5h;
Stage #2: cyclopamine With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h;
76%
2-(2,2,2-trifluoroacetamido)acetic acid succinimidyl ester
3397-30-6

2-(2,2,2-trifluoroacetamido)acetic acid succinimidyl ester

cyclopamine
4449-51-8

cyclopamine

N-(N'-trifluoroacetylglycyl)cyclopamine
334616-29-4

N-(N'-trifluoroacetylglycyl)cyclopamine

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 1h;60%
cyclopamine
4449-51-8

cyclopamine

trifluoroacetic anhydride
407-25-0

trifluoroacetic anhydride

N-trifluoroacetyl cyclopamine
334616-21-6

N-trifluoroacetyl cyclopamine

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 15℃; for 16h;56.33%
With triethylamine In dichloromethane at 20℃; for 0.166667h;51%
acetic anhydride
108-24-7

acetic anhydride

cyclopamine
4449-51-8

cyclopamine

N,3-O-diacetyl-11-deoxojervine
4243-42-9

N,3-O-diacetyl-11-deoxojervine

Conditions
ConditionsYield
With pyridine
succinic acid anhydride
108-30-5

succinic acid anhydride

cyclopamine
4449-51-8

cyclopamine

cyclopamine 3-succinate

cyclopamine 3-succinate

Conditions
ConditionsYield
With pyridine at 60℃; for 18h;80 % Spectr.
cyclopamine
4449-51-8

cyclopamine

C35H48N2O7

C35H48N2O7

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 80 percent Spectr. / pyridine / 18 h / 60 °C
2: 1,3-dicyclohexylcarbodiimide / CHCl3 / 16 h / 20 °C
View Scheme
cyclopamine
4449-51-8

cyclopamine

1,2-dichloro-ethane
107-06-2

1,2-dichloro-ethane

C29H44ClNO2
878204-94-5

C29H44ClNO2

Conditions
ConditionsYield
With potassium carbonate In dimethyl sulfoxide at 70℃; for 36h;
cyclopamine
4449-51-8

cyclopamine

benzyl chloroformate
501-53-1

benzyl chloroformate

C35H47NO4

C35H47NO4

Conditions
ConditionsYield
With triethylamine In methanol; dichloromethane at 0℃; for 3.5h;
With triethylamine In methanol; dichloromethane for 3.5h; Cooling with ice;
benzyl tert-butyl carbonate
60470-15-7

benzyl tert-butyl carbonate

cyclopamine
4449-51-8

cyclopamine

bis-CBz-cyclopamine
1037210-08-4

bis-CBz-cyclopamine

Conditions
ConditionsYield
With dmap; triethylamine In pyridine at 40℃; for 2h; Product distribution / selectivity;
With dmap; triethylamine In methanol; ethyl acetate at 40℃; for 18h; Product distribution / selectivity;
cyclopamine
4449-51-8

cyclopamine

1-benzyloxycarbonyloxy-1H-benzotriazole
59577-41-2

1-benzyloxycarbonyloxy-1H-benzotriazole

bis-CBz-cyclopamine
1037210-08-4

bis-CBz-cyclopamine

Conditions
ConditionsYield
With dmap; triethylamine In pyridine at 40℃; for 2h;
With pyridine; dmap; triethylamine at 40℃; for 2h;
cyclopamine
4449-51-8

cyclopamine

tartaric acid
87-69-4

tartaric acid

C4H6O6*2C27H41NO2

C4H6O6*2C27H41NO2

Conditions
ConditionsYield
In methanol
cyclopamine
4449-51-8

cyclopamine

C32H52N2O5
1373352-14-7

C32H52N2O5

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: aluminum isopropoxide; butanone / 6.5 h / Reflux
2: palladium 10% on activated carbon; hydrogen / pyridine / 4 h
3: ethanol; water / 1 h
4: sodium cyanoborohydride; acetic acid / methanol; 1,1-dichloroethane / 1.5 h
5: acetic acid / methanol / 40 °C
View Scheme
cyclopamine
4449-51-8

cyclopamine

C34H56N2O5
1373352-15-8

C34H56N2O5

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: aluminum isopropoxide; butanone / 6.5 h / Reflux
2: palladium 10% on activated carbon; hydrogen / pyridine / 4 h
3: ethanol; water / 1 h
4: sodium cyanoborohydride; acetic acid / methanol; 1,1-dichloroethane / 1.5 h
5: acetic acid / methanol / 40 °C
View Scheme
cyclopamine
4449-51-8

cyclopamine

C33H54N2O6
1373352-16-9

C33H54N2O6

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: aluminum isopropoxide; butanone / 6.5 h / Reflux
2: palladium 10% on activated carbon; hydrogen / pyridine / 4 h
3: ethanol; water / 1 h
4: sodium cyanoborohydride; acetic acid / methanol; 1,1-dichloroethane / 1.5 h
5: acetic acid / methanol / 40 °C
View Scheme
cyclopamine
4449-51-8

cyclopamine

C33H54N2O6
1373352-17-0

C33H54N2O6

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: aluminum isopropoxide; butanone / 6.5 h / Reflux
2: palladium 10% on activated carbon; hydrogen / pyridine / 4 h
3: ethanol; water / 1 h
4: sodium cyanoborohydride; acetic acid / methanol; 1,1-dichloroethane / 1.5 h
5: acetic acid / methanol / 40 °C
View Scheme
cyclopamine
4449-51-8

cyclopamine

C33H54N2O6
1373352-18-1

C33H54N2O6

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: aluminum isopropoxide; butanone / 6.5 h / Reflux
2: palladium 10% on activated carbon; hydrogen / pyridine / 4 h
3: ethanol; water / 1 h
4: sodium cyanoborohydride; acetic acid / methanol; 1,1-dichloroethane / 1.5 h
5: acetic acid / methanol / 40 °C
View Scheme
cyclopamine
4449-51-8

cyclopamine

C33H54N2O6

C33H54N2O6

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: aluminum isopropoxide; butanone / 6.5 h / Reflux
2: palladium 10% on activated carbon; hydrogen / pyridine / 4 h
3: ethanol; water / 1 h
4: sodium cyanoborohydride; acetic acid / methanol; 1,1-dichloroethane / 1.5 h
5: acetic acid / methanol / 40 °C
View Scheme

4449-51-8Relevant articles and documents

The Transformation of Jervine into 18-Functional C-Nor-D-homosteroids

Suginome, Hiroshi,Yonekura, Norihisa,Masamune, Tadashi

, p. 210 - 213 (1980)

N,O-Diacetyldeoxojervine, obtained by the Wolff-Kishner reduction of jervine followed by acetylation, has been catalytically hydrogenated to (22S,25S)-N,3-O-diacetyl-5α-veratranine-3β,23β-diol.Irradiation in benzene containing mercury(II) oxide and iodine afforded 20-formyl-17β-ethyl-12α-etiojervan-3β-ol 3-acetate which was converted into 17β-ethyl-3β-hydroxy-12α-etiojervan-20-one 3-acetate by dye-sensitized photo-oxygenation of the corresponding morpholine enamine.Reduction to 17β-ethyl-12α-etiojervane-3β,20β-diol 3-acetate with sodium borohydride followed by irradiation in benzene in the presence of mercury(II) oxide and iodine afforded an 18-functional C-nor-D-homosteroid, (20R)-18,20-epoxy-17β-ethyl-12α-etiojervane-3β,20β-diol.The configuration of the methyl group on the tetrahydrofuran ring has been shown to be α on the basis of the NMR spectrum, confirming a previous assignment.

11-Deoxojervine, a new alkaloid from Veratrum species.

Masamune,Mori,Takasugi,Murai,Ohuchi,Sato,Katsui

, p. 1374 - 1378 (1965)

-

A new cyclopamine glucuronide prodrug with improved kinetics of drug release

Renoux, Brigitte,Legigan, Thibaut,Bensalma, Souheyla,Chadeneau, Corinne,Muller, Jean-Marc,Papot, Sebastien

experimental part, p. 8459 - 8465 (2012/04/23)

We prepared a new glucuronide prodrug of cyclopamine designed to target selectively the Hedgehog signalling pathway of cancer cells. This prodrug includes a novel self-immolative linker bearing a hydrophilic side chain that can be easily introduced via "click chemistry". With this design, the prodrug exhibits reduced toxicity compared to the free drug on U87 glioblastoma cells. However, in the presence of β-glucuronidase, the prodrug conducts to the quick release of cyclopamine thereby restoring its antiproliferative activity. The Royal Society of Chemistry 2011.

Synthesis of cyclopamine using a biomimetic and diastereoselective approach

Giannis, Athanassios,Heretsch, Philipp,Sarli, Vasiliki,Stoessel, Anne

supporting information; experimental part, p. 7911 - 7914 (2010/03/30)

From Homer to hedgehog: Cyclopamine, the first inhibitor of the hedgehog signaling pathway, causes cyclopia in embryos butin adults it is a potent anticancer drug. A concise biomimetic and diastereoselective synthesis of cyclopamine (2) starting from comm

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4449-51-8